Fernando Albericio

Title: Innovations of Fernando Albericio

Introduction

Fernando Albericio is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of peptide synthesis and antitumoral compounds. With a total of 12 patents to his name, Albericio's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

One of his latest patents is related to diketopiperazine forming dipeptidyl linker. This invention pertains to a method for homogeneous solution phase peptide synthesis (HSPPS) of a N-terminal peptide fragment PEP-N and a C-terminal peptide fragment C-PEP. The C-PEP carries a specific diketopiperazine (DKP) that includes a C-terminal protecting group, which can be selectively cleaved from the peptide. This innovation allows for the avoidance of certain process steps in convergent peptide synthesis, enhancing efficiency in the field. Another notable patent involves antitumoral compounds of Formula I, which are useful as antitumor agents and include pharmaceutically acceptable salts, derivatives, tautomers, prodrugs, or stereoisomers.

Career Highlights

Throughout his career, Fernando Albericio has worked with esteemed institutions such as the University of Minnesota and Pharma Mar, S.A. His research has focused on advancing methodologies in peptide synthesis and developing new therapeutic agents.

Collaborations

Albericio has collaborated with notable individuals in his field, including George Barany and Jane Chang. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.

Conclusion

Fernando Albericio's contributions to the field of peptide synthesis and antitumoral compounds highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence research and development in the industry.